NEKTAR THERAPEUTICS
NEKTAR THERAPEUTICS (NKTR) is a publicly traded company in the Unknown sector. Across all available filings, 33 corporate insiders have executed 928 transactions totaling $258.0M, demonstrating a bearish sentiment with -$254.8M in net insider flow. The most recent transaction on Feb 18, 2026 involved a sale of 423 shares valued at $30.9K.
NKTR Insider Activity Summary
Who Is Buying NKTR Stock?
No significant insider buying has been recorded for NKTR in the recent period.
Who Is Selling NKTR Stock?
No significant insider selling has been recorded for NKTR in the recent period.
Is NEKTAR THERAPEUTICS Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for NKTR is bearish with an Insider Alignment Score of 1/100 and a net flow of -$254.8M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
NKTR Frequently Asked Questions
Understanding NKTR Insider Activity
Insider trading at NEKTAR THERAPEUTICS (NKTR) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 33 insiders are actively trading NKTR stock, having executed 928 transactions in the past 90 days. The most active insider is Howard W. Robin (Executive), who has made 170 transactions totaling $137.2M.
Related Tools
Track NEKTAR THERAPEUTICS Insider Activity
Get notified when executives and directors at NKTR file new Form 4 transactions